| Literature DB >> 29289682 |
Andrey I Osipyants1, Andrey A Poloznikov2, Natalya A Smirnova1, Dmitry M Hushpulian1, Anna Yu Khristichenko1, Tatiana A Chubar3, Arpenik A Zakhariants3, Manuj Ahuja4, Irina N Gaisina5, Bobby Thomas4, Abe M Brown6, Irina G Gazaryan7, Vladimir I Tishkov8.
Abstract
L-Ascorbate (L-Asc), but not D-isoascorbate (D-Asc) and N-acetylcysteine (NAC) suppress HIF1 ODD-luc reporter activation induced by various inhibitors of HIF prolyl hydroxylase (PHD). The efficiency of suppression by L-Asc was sensitive to the nature of HIF PHD inhibitor chosen for reporter activation. In particular, the inhibitors developed to compete with alpha-ketoglutarate (αKG), were less sensitive to suppression by the physiological range of L-Asc (40-100 μM) than those having a strong iron chelation motif. Challenging those HIF activators in the reporter system with D-Asc demonstrated that the D-isomer, despite exhibiting the same reducing potency with respect to ferric iron, had almost no effect compared to L-Asc. Similarly, no effect on reporter activation was observed with cell-permeable reducing agent NAC up to 1 mM. Docking of L-Asc and D-Asc acid into the HIF PHD2 crystal structure showed interference of Tyr310 with respect to D-Asc. This suggests that L-Asc is not merely a reducing agent preventing enzyme inactivation. Rather, the overall results identify L-Asc as a co-substrate of HIF PHD that may compete for the binding site of αKG in the enzyme active center. This conclusion is in agreement with the results obtained recently in cell-based systems for TET enzymes and jumonji histone demethylases, where L-Asc has been proposed to act as a co-substrate and not as a reducing agent preventing enzyme inactivation.Entities:
Keywords: Adaptaquin; Catalytic cycle; HIF PHD inhibitor; HIF1 ODD-Luciferase reporter assay; Jumonji demethylase; TET enzyme
Mesh:
Substances:
Year: 2017 PMID: 29289682 PMCID: PMC6460286 DOI: 10.1016/j.biochi.2017.12.011
Source DB: PubMed Journal: Biochimie ISSN: 0300-9084 Impact factor: 4.079